None
The present disclosure relates to a testing system for pathogens.
In general, a testing device and related method is designed with a piston, which may include a piston chamber, a first retention portion, an annular lower portion, a pierceable layer spanning the annular lower portion's center, a textured surface at a bottom end of the piston, the piston chamber capable of retaining a fluid. A testing device may include a core, with a first core chamber, a second core chamber, a second retention portion, at least one lower drain hole, an annular grinding surface, an assay opening, and a piercing element. A testing device may include a plunger, with at least one hole plug protruding from a top portion of the plunger, a circumferential sealing element, and a retaining element; and may also include an assay section, with a test strip, an indicator window, and a plunger retaining element.
The piston may be operatively connectable to the core such that pressing the piston into the first core chamber causes the piercing element to pierce the pierceable layer, with the piston capable of rotating inside of the core chamber. The plunger may be operatively connectable to the core such that extending the plunger relative to the core removes the at least one hole plug from the at least one drain hole. The first core chamber may be capable of receiving a test specimen prior to the piston being inserted into the core, allowing the test specimen to be ground between the textured surface and the grinding surface.
The textured surface may contact the grinding surface when the piston is pressed fully into the core. The buffer liquid contained in the piston chamber may flow into the core chamber when the pierceable layer is pierced. Extending the plunger relative to the core may allow a combination of the buffer liquid and the test specimen to flow through the at least one hole from the first core chamber to the second core chamber. A combination of the buffer liquid and the test specimen may pass through the assay opening to make fluid contact with the test strip. The test strip may be configured to detect and indicate the presence of pathogens in a combination of the buffer liquid and the test specimen, where the indication may be visual and viewable on the test strip through the indicator window. Pathogens detected may be from a test specimen that is a tick.
The piercing element may include a sculpted surface. The plunger may include a base which allows the testing device to stand in a vertical position. The textured surface may be contained on a texture plate, the texture plate affixable to the annular lower portion of the piston. The pierceable layer may be positioned between the texture plate and the annular lower portion of the piston. Rotation of the piston, with the piston fully compressed into the core, may cause the test specimen to be ground and biological contents to be released into the buffer liquid. The piston's first retention portion may engage with the core's second retention portion. The assay's plunger retaining element may engage with the core's retaining element to prevent the plunger from being removed from the core.
There is also a testing device that may include a vial with a first closed end and an opposing open end, the open end capable of receiving a test specimen and a buffer liquid; a sliding member with a cap end and an opposing cylindrical end, the two ends connected by a rod, the cap end containing a slot, with a filter positioned at the end of the slot facing the cylindrical end. The sliding member may be configured to be slidable inside of the vial and capable of crushing the test specimen against the first closed end. In conjunction with the above, a lateral flow assay device may be used, with an elongated tip, the tip configured to enter the filter through the slot, the lateral flow assay device configured to detect and indicate the presence of pathogens in a combination of the buffer liquid and the test specimen.
The present system relates to a testing system for pathogens or analytes that may be present in a test specimen. In one embodiment, the device may be used to determine whether test specimens such as ticks contain pathogens that can cause diseases including but not limited to Anaplasmosis, Babesiosis, Ehrlichiosis, Heartland Virus, Lyme Disease, Powassan Virus, Rickettsiosis, Rocky Mountain Spotted Fever, Southern Tick Associated Rash Illness, Tick-Borne Relapsing Fever, and Tularemia. In another embodiment, the device may be used to determine whether other biological test specimens contain analytes such as pharmaceutical drugs, allergens, narcotics, non-microbial contaminants, toxins, ions, or other small organic or non-organic molecules.
The device may also be used for the preparation and testing of other test specimen and biological matter types, including but not limited to: various insect types, fecal samples, meat, fish, vegetables, legumes or fruits, grain, dirt, minerals, water, bodily tissue (as in a biopsy sample), renal calculus, hair, blood, serum, saliva, semen, synovial fluid, cerebrospinal fluid, lotion, leaf, grass, vegetation, flower, root, or stem, any which may carry a variety of pathogen types. Thus, reference to tick or insect may be interchanged with at least any of the above types for purposes of this disclosure.
Through this disclosure buffer, or buffer liquid, may refer to a common solution as known in the art. It may include buffering agents to stabilize pH, lysing agents, surfactants, and other ingredients as appropriate for an application. Embodiments in the disclosure may be manufactured by any means in the art, such as but not limited to plastic injection molding, machining, 3-D printing, etc.
Referring to
The inside of the closed end of vial 15 may be conical-shaped. Similarly, second end 30 with ridges 35 may have a similar curved surface to accelerate the process of grinding a test specimen when cap 25 is inserted, closed, and moved back-and-forth and/or rotated in a circular motion. Cap 25 may include a closure that locks into the top of vial 15 to ensure no spillage if the vial-sliding member assembly is in a non-vertical position.
A first step in testing, such as testing a tick for various pathogens, involves crushing and sample preparation. A tick or insect is placed into vial 15, and approximately 1 mL of buffer liquid is added into vial 15. The buffer liquid may be provided in ampoule or other suitable container. Sliding member 10 is inserted into vial 15, with cap 25 inserted into vial 15 and closed securely. A user then holds vial 15 upright and rotates (or uses and up-and-down motion) cap 10 a plurality of times, thereby crushing the insect and releasing its inner biological contents and any bacteria potentially within.
The next testing step involves placing tip 110 of the lateral flow assay device into slot 27. The assembly of vial 15 and sliding member 10 is then turned 90 degrees onto its side to allow the crushed insect liquid to flow onto filter 40, thereby making contact with paper tip 110. Insect bacteria is carried by the buffer liquid, with any solid matter from the insect not capable of passing through filter 40 and reaching paper tip 110. The assay device includes, internally, suitable analytic chemicals and/or mechanisms to determine the presence of pathogens of interest absorbed by paper tip 110. Different analytics are used to detect pathogens of interest for specific applications. The user then waits a predetermined amount of time until a result appears in the viewing window 120, either positive or negative, indicating presence or absence of a pathogen.
If an insect to be tested is attached to the body of a creature (human, dog, etc.) remover 200 may be used to help remove the insect. Claw 20 may be wedged between an insect and a creature's skin, with the insect pried away. Tweeze ends 210 may also be used.
Piston 400 may be configured with a textured surface 405 its bottom end. The textured surface may be part of piston 400 itself, or may be a separate texture plate 422 that can be affixed to piston 400. Texture plate 422 may be affixed to piston 400 after the pierceable layer 410 is applied to the annular lower portion 425. A separate texture plate 422 can be seen in
The exploded view of
Core 440 may be configured with a second core chamber 480, positioned below first core chamber 475. The two chambers 475 and 480 are in fluid communication with each other through at least one lower drain hole 460. Second core chamber 480 is configured with an assay opening 465, which allows fluid communication with assay section 518, including test strip 520. Test strip 520 may be of any suitable type known in the art. It may be made of nitrocellulose paper, or other suitable material.
The exploded view of
Referencing
The system may be designed to function in a number of different ways, including the following. A user begins with the system as configured from manufacturing with plunger 490 fully seated into core 440, assay section 518 affixed to core 440, with piston 400 separated from core 440. Piston chamber 435 contains an appropriate amount of buffer liquid, which was installed during manufacturing, with pierceable layer 410 sealing the buffer liquid in piston chamber 435.
A user places a test specimen such as 600 into first core chamber 475, wherein it rests on annular grinding surface 485, which may include a textured surface. Piston 490 is then fully inserted to first core chamber 475. Such insertion causes piercing element 450 to pierce pierceable layer 410, causing the buffer liquid to be released into first core chamber 475. Sculpted surface 455 on piercing element 450 in part allows the buffer liquid to flow into the chamber.
A user imparts motion to piston 400, while holding the core in place. Motion may be rotations of piston 400 and/or an up-and-down motion—both serve to grind the test specimen between textured surface 405 and annular grinding surface 485. The dimension of first retention portion 430 relative to the groove on second retention portion 470 may be such that a small amount of up-and-down motion is possible, with 430 movable within 470. After the test specimen is ground as desired, the inner biological contents of the test specimen (such as insect internal matter and pathogens) will form a combination with the buffer liquid.
The user then extends plunger 490 relative to core 440, which removes the at least one hole plug 495 from the at least one lower drain hole 460, causing the combination to drain into second core chamber 480. The combination may then travel through assay opening 465. This allows the combination to be in fluid contact with test strip 520. Retaining element 515 in combination with plunger retaining element 530 prevents plunger 490 from being over-extended and removed from core 440.
The test strip includes, internally, suitable analytic chemicals and/or mechanisms to determine the presence of pathogens of interest absorbed by the test strip. Different analytics are used to detect pathogens of interest for specific applications. The user then waits a predetermined amount of time until a result appears in the indicator window 525, either positive or negative, indicating presence or absence of a pathogen.
Although the present system has been described with respect to one or more embodiments, it will be understood that other embodiments of the present system may be made without departing from the spirit and scope of the present system. Hence, the present system is deemed limited only by claims and the reasonable interpretation thereof.
This application claims the benefit of provisional application No. 63/238,860 filed Aug. 31, 2021; and provisional application No. 63/371,803 filed Aug. 18, 2022; the entire disclosures of the parent applications are incorporated herein by reference.
| Number | Date | Country | |
|---|---|---|---|
| 63238860 | Aug 2021 | US | |
| 63371803 | Aug 2022 | US |